New book by Larry Connors Click here Improve your trading - See how
DATE POSTED: 01-SEP-09 AGENCY: Department of Health and Human Services OFFICE ADDRESS: Bldg 427, Room 12 Frederick MD 21702 SUBJECT: Highly Potent Cancer Therapeutics using Nanotechnology CLASSIFICATION CODE: A - Research & Development SOLICITATION NUMBER: S10-028 CONTACT: Lynne Darby, Senior Subcontract Specialist, Phone 301 228 4021, Fax 301 228 4037, Email darbyl@mail.nih.gov SETASIDE: N/A PLACE OF PERFORMANCE ADDRESS: Contractor's site. PLACE OF PERFORMANCE COUNTRY: US NOTICE TEXT: Department of Health and Human Services National Institutes of Health National Cancer Institute RFP S10-028. PROPOSALS MUST BE RECEIVED BY 3:00 P.M., Eastern Daylight Time, September 29, 2009. It is the Offerors responsibility to ensure that proposals are delivered by the due date and time required. Late proposals will not be accepted. All questions or requests for clarifications must be e-mailed (No telephone calls accepted) to Lynne Darby at darbyl@mail.nih.gov, or by facsimile at 301-228-4037 by 3:00 P.M., Eastern Daylight Time, September 15, 2009. Questions or requests directed to any other individual or outside the directives of this Solicitation will not be considered valid, nor will there be a response provided. SAIC-Frederick, Inc., on behalf of the The National Cancer Institute, NCI, is seeking offerors to submit proposals for nanotherapeutics that are in the post-optimization phase of the development cycle, and require evaluation in appropriate preclinical animal models of the disease for determination of both efficacy and safety profiles of the nanodevice and the targeted chemotherapeutic payload. The purpose of this Request for Proposals (RFP) is to identify and evaluate the potential of candidate nanotechnologies to improve the bioavailability, solubility, pharmacokinetics, or therapeutic index of a range of drugs that would otherwise fail as anti-cancer agents. The NCI Alliance for Nanotechnology is interested in identifying these technologies at academic institutions, nanotechnology-focused pharmaceutical companies, and biotechnology companies.This acquisition shall be conducted in a two-Phase approach. Once received, all proposals will be evaluated on the basis of technical merit, and a decision will be made to select a minimum of one, and possibly multiple awards.Specifics are outlined in detail in the attached Request for Proposals, S10-028. INTERNET ADDRESS: https://www.fbo.gov/spg/HHS/NIH/FCRF/S10-028/listing.html Provided by Federal Information & News Dispatch, Inc. (FIND) 202-429-5944 For full details for CTHP click here.
Email Print Archives Feedback Email Article Link
Close X
Related News [CTHP]
UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
Thursday December 3 12:30 PM
* Attendance is strictly limited and are filled on a first-come, first-served basis.
The TradingMarkets Directory
Stocks
Options
Forex
E-mini/Futures
How to Trade
Tools
PowerRatings
Blogs
Premium Subscription Services
RELATED SITES
Please call 1-213-955-5858 ext. 1
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice. It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment. HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN. The Connors Group, Inc. © Copyright 2009 The Connors Group, Inc. All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy. © 2009 The Connors Group, Inc.
|
